
Sign up to save your podcasts
Or
In which Sam, Richard and Gaby talk about the new long-acting injectable PrEP agent, cabotegravir - reviewing efficacy, side effects and how this all fits into a larger landscape of HIV prevention and equity.
4.9
4040 ratings
In which Sam, Richard and Gaby talk about the new long-acting injectable PrEP agent, cabotegravir - reviewing efficacy, side effects and how this all fits into a larger landscape of HIV prevention and equity.
38,409 Listeners
6,136 Listeners
90,253 Listeners
27,226 Listeners
695 Listeners
8,372 Listeners
14,505 Listeners
112,319 Listeners
14,825 Listeners
15,728 Listeners
464 Listeners
3,295 Listeners
14,604 Listeners
3,959 Listeners
8,238 Listeners